Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants
NCT ID: NCT03539016
Last Updated: 2018-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2015-07-31
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Model for Prognosis of Chronic HBV Infection Mothers
NCT04805034
HBV DNA Levels During Pregnancy in Chronic Hepatitis B
NCT01610115
Observational Study on Patients With Chronic Hepatitis B
NCT02167503
Mother-to-child Transmission of HBV in China
NCT05172453
The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus Infection
NCT03214302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. HBsAg+ \> 6 months, HBeAg+/-
3. Informed consent signed voluntarily
4. Good compliance and able to be followed up as planned
Exclusion Criteria
2. Comorbidities of other severe conditions that hinder compliance with follow ups and because of that, the subjects are anticipated to be unable to complete the project.;
3. Unable or unwilling to use mobile health tools.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tigermed Consulting Co., Ltd
INDUSTRY
Nanfang Hospital, Southern Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nanfang Hospital
Guangzhou, Guangdong, China
302 military hospital of China
Beijing, , China
Beijing YouAn Hospital
Beijing, , China
Fifth Affiliated Hospital of Southern Medical University
Guangzhou, , China
Guangzhou No. 8 People's Hospital
Guangzhou, , China
Third Affiliated Hospital of Southern Medical University
Guangzhou, , China
Zhujiang Hospital
Guangzhou, , China
Jiujiang Maternal and Child Care Service Centre
Jiujiang, , China
Third Hospital of Jiujiang
Jiujiang, , China
Second Hospital of Nanjing
Nanjing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHIELD-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.